HSPCs and off-target effects of CRISPR-Cas9 : vimarsana.com

This article describes the characterization of genome integrity in clinically relevant human hematopoietic stem and progenitor cells (HSPCs) following the use of CRISPR-Cas9 MaxCyte®.

Related Keywords

Maria Osipova , Maxcyte Inc Apr , Maxcyte Inc , , Sponsored Content , Inc Apr , Image Credit , Creative Commons License Attribution , Wide Analysis , Single Cell Derived Human Hematopoietic Stem , Progenitor Cell , Flow Electroporation , Content Policy , News Medical Net , Human Hematopoietic Stem , Progenitor Cells , Ff Target Effects , Crispr Cas9 , Cells , Maxcyte Electroporation ,